USD 1.95
(-2.5%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | - USD | 0.0% |
2022 | - USD | 100.0% |
2021 | -2.98 Million USD | -432.8% |
2020 | -561 Thousand USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 100.0% |
2016 | -619 Thousand USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
2004 | - USD | 0.0% |
2003 | - USD | 0.0% |
2002 | - USD | 0.0% |
2001 | - USD | 0.0% |
2000 | - USD | 0.0% |
1999 | - USD | 0.0% |
1998 | - USD | 0.0% |
1997 | - USD | 0.0% |
1996 | - USD | 0.0% |
1995 | - USD | 0.0% |
1994 | - USD | 0.0% |
1993 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | - USD | 100.0% |
2024 Q1 | -1.71 Million USD | 0.0% |
2023 Q4 | - USD | 0.0% |
2023 FY | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2022 Q4 | - USD | 0.0% |
2022 Q2 | - USD | 0.0% |
2022 FY | - USD | 100.0% |
2022 Q1 | - USD | 0.0% |
2022 Q3 | - USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2021 FY | -2.98 Million USD | -432.8% |
2021 Q2 | - USD | 0.0% |
2021 Q1 | - USD | 0.0% |
2021 Q4 | - USD | 0.0% |
2020 Q4 | - USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 FY | -561 Thousand USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 FY | - USD | 100.0% |
2017 Q4 | - USD | 0.0% |
2017 Q1 | - USD | 100.0% |
2016 Q1 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q4 | -619 Thousand USD | 0.0% |
2016 FY | -619 Thousand USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2005 Q1 | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2004 Q1 | - USD | 0.0% |
2004 Q2 | - USD | 0.0% |
2004 Q3 | - USD | 0.0% |
2004 Q4 | - USD | 0.0% |
2004 FY | - USD | 0.0% |
2003 Q1 | - USD | 0.0% |
2003 Q4 | - USD | 0.0% |
2003 Q2 | - USD | 0.0% |
2003 Q3 | - USD | 0.0% |
2003 FY | - USD | 0.0% |
2002 Q1 | - USD | 0.0% |
2002 FY | - USD | 0.0% |
2002 Q2 | - USD | 0.0% |
2002 Q4 | - USD | 0.0% |
2002 Q3 | - USD | 0.0% |
2001 Q1 | - USD | 0.0% |
2001 Q4 | - USD | 0.0% |
2001 Q3 | - USD | 0.0% |
2001 Q2 | - USD | 0.0% |
2001 FY | - USD | 0.0% |
2000 Q2 | - USD | 0.0% |
2000 Q3 | - USD | 0.0% |
2000 Q4 | - USD | 0.0% |
2000 FY | - USD | 0.0% |
2000 Q1 | - USD | 0.0% |
1999 Q2 | - USD | 0.0% |
1999 FY | - USD | 0.0% |
1999 Q4 | - USD | 0.0% |
1999 Q1 | - USD | 0.0% |
1999 Q3 | - USD | 0.0% |
1998 Q1 | - USD | 0.0% |
1998 Q2 | - USD | 0.0% |
1998 Q3 | - USD | 0.0% |
1998 Q4 | - USD | 0.0% |
1998 FY | - USD | 0.0% |
1997 FY | - USD | 0.0% |
1997 Q1 | - USD | 0.0% |
1997 Q2 | - USD | 0.0% |
1997 Q3 | - USD | 0.0% |
1997 Q4 | - USD | 0.0% |
1996 Q1 | - USD | 0.0% |
1996 FY | - USD | 0.0% |
1996 Q4 | - USD | 0.0% |
1996 Q2 | - USD | 0.0% |
1996 Q3 | - USD | 0.0% |
1995 Q4 | - USD | 0.0% |
1995 FY | - USD | 0.0% |
1995 Q3 | - USD | 0.0% |
1995 Q1 | - USD | 0.0% |
1995 Q2 | - USD | 0.0% |
1994 FY | - USD | 0.0% |
1994 Q4 | - USD | 0.0% |
1994 Q2 | - USD | 0.0% |
1994 Q3 | - USD | 0.0% |
1993 FY | - USD | 0.0% |
1993 Q4 | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
AIM ImmunoTech Inc. | -1.18 Million USD | 100.0% |
Ampio Pharmaceuticals, Inc. | 1.00 USD | 100.0% |
Actinium Pharmaceuticals, Inc. | - USD | NaN% |
Azitra, Inc. | -215.21 Thousand USD | 100.0% |
Can-Fite BioPharma Ltd. | - USD | NaN% |
Chromocell Therapeutics Corporation | - USD | NaN% |
Calidi Biotherapeutics, Inc. | - USD | NaN% |
CEL-SCI Corporation | 2.24 Million USD | 100.0% |
iBio, Inc. | - USD | NaN% |
Lineage Cell Therapeutics, Inc. | - USD | NaN% |
MAIA Biotechnology, Inc. | - USD | NaN% |
Matinas BioPharma Holdings, Inc. | - USD | NaN% |
Navidea Biopharmaceuticals, Inc. | 427.34 Thousand USD | 100.0% |
NovaBay Pharmaceuticals, Inc. | 2.87 Million USD | 100.0% |
NanoViricides, Inc. | - USD | NaN% |
Oragenics, Inc. | - USD | NaN% |
BiomX Inc. | - USD | NaN% |
BiomX Inc. | - USD | NaN% |
Protalix BioTherapeutics, Inc. | 19.04 Million USD | 100.0% |
Palatin Technologies, Inc. | - USD | NaN% |
Scorpius Holdings, Inc. | 909.15 Thousand USD | 100.0% |